Stay updated on Bumetanide Oral Liquid in ASD Children Clinical Trial
Sign up to get notified when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.

Latest updates to the Bumetanide Oral Liquid in ASD Children Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes regarding a study on Autism Spectrum Disorder (ASD) and the treatment with bumetanide, including the removal of detailed study descriptions and inclusion/exclusion criteria, while retaining some core information about the study design.SummaryDifference13%
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Bumetanide Oral Liquid in ASD Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.